Travere Therapeutics Inc
TVTX
NASDAQ
Biotechnology
$62.14
USD
+0.71 (+1.16%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $5.79B
Volume 1.2M
Price Target
$60.00 – $70.00
USD
The 6 analysts offering 1-year price forecasts have a max estimate of $70.00 and a min estimate of $60.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$64.67
+$10.4 vs prior
Implied Upside
+4.1%
+16.8% vs prior
Analyst Covering
6
-2 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
43%
A mix of recent and older ratings shape this consensus
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0.3300 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
6 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
6
Hold
0
Sell
0
Strong Sell
0
6 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Vamil Divan | Guggenheim | Buy | Maintained | 1 month ago | Plus | Plus | Plus |
Laura Chico | Wedbush | Buy | Maintained | 1 month ago | Plus | Plus | Plus |
Liisa Bayko | Evercore ISI Group | Buy | Maintained | 1 month ago | Plus | Plus | Plus |
Yigal Nochomovitz | Citigroup | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Mohit Bansal | Wells Fargo | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
